MetaCap

Aclarion (ACON) vs Advanced Biomed (ADVB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Aclarion is the larger company by market cap ($3.5 million vs $2.7 million), about 1.3 times the size. Advanced Biomed converts more of its revenue into profit, with a net margin of 5231.3% versus -9551.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACON-47.98%ADVB-73.43%
+4%-37%-77%
Oct 7, 20261 yearNov 20, 2026
ACON-47.76%ADVB-68.93%
+3%-34%-72%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACON versus ADVB key metrics
MetricACONADVB
Share price$1.22$1.65
Market cap$3.52M$2.73M
1-day change-13.92%-5.71%
YTD return—-71.75%
1-year return—-77.76%
EPS (TTM)$-5.01$-5.03
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$75.73K$127.64K
Revenue growth (YoY)+65.62%—
Net income (latest FY)$-7.23M$6.68M
Gross margin9.02%—
Operating margin-9312.55%-4883.80%
Net margin-9551.87%5231.30%
52-week high$9.36$24.23
52-week low$1.22$1.58
Distance from 52-week high-86.94%-93.19%
Analyst consensusstrong_buy—
Avg. price target upside+524.18%—
Average volume34.73K88.38K
Shares outstanding2.88M1.65M
Employees1031
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Advanced Biomed is more profitable, keeping 5231.3 cents of every revenue dollar as net income versus -9551.9 cents for Aclarion.

About Aclarion

ACON stock →

Aclarion, Inc. operates as a healthcare technology company in the United States.

Health Care · Medical Specialities · 10 employees

About Advanced Biomed

ADVB stock →

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product.

Health Care · Medical Specialities · 31 employees

ACON vs ADVB FAQ

Which is bigger, Aclarion or Advanced Biomed?

Aclarion (ACON) is larger, with a market capitalization of $3.52M compared with $2.73M for Advanced Biomed (ADVB).

Are Aclarion and Advanced Biomed in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons